Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Sell
48,473
-1,245
-3% -$65.8K 1.43% 16
2026
Q1
$2.74M Buy
49,718
+2,242
+5% +$121K 1.75% 15
2025
Q4
$2.33M Buy
+47,476
New +$2.21M 1.52% 15

Other funds holding GSK

Christine Messmer PC's GSK Position: Q2 2026 in Review

Christine Messmer PC reduced its GSK (GSK) stake by 2.5% in Q2 2026, selling an estimated $65.8K and leaving 48,473 shares worth $2.54M. The position accounts for 1.43% of the portfolio, ranked #16.

Christine Messmer PC first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.74M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Christine Messmer PC held 48,473 shares of GSK worth $2.54M as of Q2 2026.
  • Christine Messmer PC sold 1,245 GSK shares in Q2 2026, an estimated $65.8K.
  • GSK made up 1.43% of Christine Messmer PC's portfolio in Q2 2026, its #16 holding.
  • Christine Messmer PC first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Christine Messmer PC's GSK position peaked at $2.74M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Christine Messmer PC's 13F filing for Q2 2026, filed 23 Jul 2026.